- Quarterly
- Annual
- TTM
-
Export .csv
-
Download Image
-
Copy link
-
Embed code
Share URL
Bar Chart preview
Jinling Pharmaceutical Company Limited EBITDA is USD 27.82 M for the year ending December 31, 2024, a -20.88% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses. Jinling Pharmaceutical Company Limited EBITDA for the year ending December 31, 2023 was USD 35.16 M, a -4.75% change year over year. Jinling Pharmaceutical Company Limited EBITDA for the year ending December 31, 2022 was USD 36.91 M, a -27.94% change year over year. Jinling Pharmaceutical Company Limited EBITDA for the year ending December 31, 2021 was USD 51.23 M, a 41.44% change year over year. Jinling Pharmaceutical Company Limited EBITDA for the year ending December 31, 2020 was USD 36.22 M, a -19.36% change year over year.
Embed chart view
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max